Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 2Sanofi
02 3Cohance Lifesciences
03 2Dr. Reddy's Laboratories
04 1Taro Pharmaceutical Industries
05 3Alfred E Tiefenbacher GmbH
06 1NanoAlvand
07 4Accord healthcare
08 1Actavis Inc
09 1Amneal Pharmaceuticals
10 1Arrotex Pharmaceuticals
11 2Aurobindo Pharma Limited
12 2Bayer AG
13 1Biocon
14 1CHEMO
15 1DelNova Healthcare
16 2Deva Holding AS
17 1Devatis AG
18 1Dr Reddy's Laboratories (Australia) Pty Ltd
19 2EG Spa
20 1ENDO OPERATIONS
21 1Farmatek
22 1Fresenius Kabi USA
23 1Fresenius SE & Co. KGaA
24 1GLAND PHARMA LIMITED
25 1Glenmark Pharmaceuticals
26 2Hainan Poly Pharm
27 3Health Biotech
28 1Hetero Drugs
29 1Hikma Pharmaceuticals
30 1Indoco Remedies Limited
31 1Inventia Healthcare Limited
32 1JAMP PHARMA
33 1Juno Pharmaceuticals Pty Ltd
34 1KMS Health Center
35 3MERCK CANADA INC
36 1MINT PHARMACEUTICALS INC
37 1MSD INTL GMBH
38 1Mallinckrodt Pharmaceuticals
39 18Merck & Co
40 1Pantson Pharma Pvt. Limited
41 1Pharmacore Inc
42 1Polifarma
43 4Sandoz B2B
44 1Sinotherapeutics
45 1Teva Pharmaceutical Industries
46 1Tillomed Laboratories Ltd
47 9Viatris
48 1Westminster Pharmaceutical
49 1Zentiva
50 1i3 Pharmaceuticals
01 1CONCENTRATE FOR SOLUTION FOR INFUSION
02 1Concentrate to the infusion fluid
03 1DR Tablet
04 1Delayed Release Pellet
05 2Delayed Release Tablet
06 1Enteric Coated Tablet
07 1Enteric Tablet
08 1FOR SUSPENSION, DELAYED RELEASE;ORAL
09 1Film Coated Tablet
10 4Filmtabl
11 1GASTRO
12 2Gastro Retentive Tablet
13 2Gastro-Resistant Tablet Oral Use Blister
14 5Gastro-Resistant Tablets
15 1Granules
16 1IV Solution for Infusion
17 1Inf Conc
18 3Injection
19 1ORAL SUSPENSION
20 1Oral Solid Dosage Form
21 8Oral Suspension
22 1Posaconazolo 100Mg 24 Units Of Oral Use
23 1Posaconazolo 40Mg/Ml 105Ml Oral Use
24 1Potion, suspension
25 1SOLUTION
26 6SOLUTION;INTRAVENOUS
27 1SUS
28 2SUSPENSION
29 1SUSPENSION; ORAL
30 2SUSPENSION;ORAL
31 5Susp
32 1Suspension
33 1TAB
34 5TABLET (DELAYED-RELEASE)
35 12TABLET, DELAYED RELEASE;ORAL
36 6Tabl
37 2Tabl Gastro-Resistant
38 2Tablet
39 1Vial
40 5Blank
01 1Countries Registered In: Under Development for US & EU
02 2DISCN
03 4Generic
04 1Lead Market Dossiers- Filed
05 2Originator
06 8Prescription
07 19RX
08 2Status- Under Registration
09 57Blank
01 1GLN-POSACONAZOLE
02 1JAMP POSACONAZOLE
03 1MINT-POSACONAZOLE
04 6NOXAFIL
05 1NOXAFIL POWDERMIX KIT
06 13Noxafil
07 1Noxafil 40mg/ml
08 1Noxafil Tablet 100mg
09 17POSACONAZOLE
10 1POSACONAZOLE ACCORD
11 1POSACONAZOLE DR.REDDY'S
12 1POSACONAZOLE EG STADA
13 1POSACONAZOLE FRESENIUS KABI
14 1POSACONAZOLE MYLAN
15 1POSACONAZOLE MYLAN PHARMA
16 1POSACONAZOLE STADA
17 1POSACONAZOLE TEVA
18 1POSACONAZOLE TILLOMED
19 1POSACONAZOLE ZENTIVA
20 3POSANOL
21 1Pharmacor Posaconazole
22 1Pixana
23 1Posaconazole ARX
24 3Posaconazole Accord
25 1Posaconazole Devatis
26 1Posaconazole Juno
27 3Posaconazole Mylan
28 3Posaconazole Sandoz
29 3Posaconazole Viatris
30 2Posaconazole Zentiva
31 1SANDOZ POSACONAZOLE
32 1TARO-POSACONAZOLE
33 20Blank
01 5Australia
02 8Canada
03 2China
04 2Germany
05 12India
06 1Iran
07 13Italy
08 3Norway
09 2South Africa
10 1Spain
11 3Sweden
12 18Switzerland
13 4Turkey
14 22USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Posaconazole Zentiva
Dosage Form : Tabl
Dosage Strength : 100mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2022-04-07
Application Number : 212500
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2021-02-01
Application Number : 213454
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Iran
Brand Name : Pixana
Dosage Form : Vial
Dosage Strength : 300MG/16.7ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Posaconazole Zentiva
Dosage Form : Tabl
Dosage Strength : 100mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Granules
Dosage Strength : 16.39%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Delayed Release Pellet
Dosage Strength : 16.39%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : TARO-POSACONAZOLE
Dosage Form : TABLET (DELAYED-RELEASE)
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 2543311
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Status- Under Registration
Registration Country : Germany
Brand Name :
Dosage Form : Gastro Retentive Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Under Registration
Registration Country : Germany
Regulatory Info : Status- Under Registration
Registration Country : Germany
Brand Name :
Dosage Form : Gastro Retentive Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Under Registration
Registration Country : Germany
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2022-11-30
Application Number : 207355
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2022-12-22
Application Number : 216626
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 300MG/16.7ML (18MG/ML)
Packaging :
Approval Date : 2023-12-26
Application Number : 214842
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NOXAFIL
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 40MG/ML
Packaging :
Approval Date : 2006-09-15
Application Number : 22003
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NOXAFIL
Dosage Form : SUSPENSION; ORAL
Dosage Strength : 40MG/ML
Packaging :
Approval Date :
Application Number : 22027
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2022-02-04
Application Number : 214476
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 300MG/16.7ML (18MG/ML)
Packaging :
Approval Date : 2023-12-26
Application Number : 209983
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2022-12-08
Application Number : 214321
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 40MG/ML
Packaging :
Approval Date : 2020-05-15
Application Number : 208773
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2023-08-28
Application Number : 216488
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2022-05-10
Application Number : 212226
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NOXAFIL
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2013-11-25
Application Number : 205053
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NOXAFIL
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 300MG/16.7ML (18MG/ML)
Packaging :
Approval Date : 2014-03-13
Application Number : 205596
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NOXAFIL POWDERMIX KIT
Dosage Form : FOR SUSPENSION, DELAYED RELEASE;ORAL
Dosage Strength : 300MG
Packaging :
Approval Date : 2021-05-31
Application Number : 214770
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2019-08-21
Application Number : 212411
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 300MG/16.7ML (18MG/ML)
Packaging :
Approval Date : 2023-12-26
Application Number : 211500
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2023-06-20
Application Number : 216326
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSACONAZOLE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 300MG/16.7ML (18MG/ML)
Packaging :
Approval Date : 2022-05-25
Application Number : 208768
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?